| Ident. | Authors (with country if any) | Title |
|---|
| 000018 (2013) |
M Van Der Mark ; Vermeulen ; Huss ; Nijssen ; Kromhout | 282 Occupational exposure to pesticides and Parkinson Disease |
| 000019 (2013) |
M A Harris [Canada] ; Marion [Canada] ; Tsui [Canada] ; Shen [Canada] ; Teschke [Canada] | 281 Occupations and Parkinson’s disease in a population-based case-control study |
| 000049 (2012) |
Steven P. Braithwaite [États-Unis] ; Jeffry B. Stock ; M. Maral Mouradian [États-Unis] | α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease |
| 000063 (2012) |
Gregory L. Willis [Australie] ; Cleo Moore [Australie] ; Stuart M. Armstrong [Australie] | Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease |
| 000092 (2011) |
Michael Eller [Australie] ; David R. Williams | α-Synuclein in Parkinson disease and other neurodegenerative disorders |
| 000095 (2011) |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
| 000096 (2011) |
Neil K. Archibald [Royaume-Uni] ; Mike P. Clarke [Royaume-Uni] ; Urs P. Mosimann [Royaume-Uni, Suisse] ; David J. Burn [Royaume-Uni] | Visual symptoms in Parkinson's disease and Parkinson's disease dementia |
| 000097 (2011) |
James M. Shine [Australie] ; Glenda M. Halliday [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie] | Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? |
| 000099 (2011) |
Turi O. Dalaker [Norvège, États-Unis] ; Robert Zivadinov [États-Unis] ; Deepa Preeti Ramasamy [États-Unis] ; Mona K. Beyer [Norvège] ; Guido Alves [Norvège] ; Kolbjorn S. Bronnick [Norvège] ; Ole-Bjorn Tysnes [Norvège] ; Dag Aarsland [Norvège] ; Jan P. Larsen [Norvège] | Ventricular enlargement and mild cognitive impairment in early Parkinson's disease |
| 000100 (2011) |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia |
| 000101 (2011) |
Sun Ju Chung [États-Unis, Corée du Sud] ; Sebastian M. Armasu [États-Unis] ; Joanna M. Biernacka [États-Unis] ; Timothy G. Lesnick [États-Unis] ; David N. Rider [États-Unis] ; Julie M. Cunningham [États-Unis] ; Demetrius M. Maraganore [États-Unis] | Variants in estrogen‐related genes and risk of Parkinson's disease |
| 000102 (2011) |
Samantha A. Hollingworth [Australie] ; Amanda Rush [Australie] ; Wayne D. Hall [Australie] ; Mervyn J. Eadie [Australie] | Utilization of anti‐Parkinson drugs in Australia: 1995–2009 |
| 000103 (2011) |
Yoichiro Kikuchi [Japon] ; Takao Yasuhara [Japon] ; Takashi Agari [Japon] ; Akihiko Kondo [Japon] ; Satoshi Kuramoto [Japon] ; Masahiro Kameda [Japon] ; Tomohito Kadota [Japon] ; Tanefumi Baba [Japon] ; Naoki Tajiri [Japon] ; Feifei Wang [Japon] ; Judith T. Tayra [Japon] ; Hanbai Liang [Japon] ; Yasuyuki Miyoshi [Japon] ; Cesario V. Borlongan [États-Unis] ; Isao Date [Japon] | Urinary 8‐OHdG elevations in a partial lesion rat model of parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion |
| 000105 (2011) |
S. Orimo [Japon] ; T. Uchihara [Japon] ; T. Kanazawa [Japon] ; Y. Itoh [Japon] ; K. Wakabayashi ; A. Kakita [Japon] ; H. Takahashi [Japon] | Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease |
| 000107 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
| 000108 (2011) |
| Twenty Fifth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 000109 (2011) |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease |
| 000110 (2011) |
P. Barone [Italie] | Treatment of depressive symptoms in Parkinson’s disease |
| 000112 (2011) |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial |
| 000114 (2011) |
Mildred D. Gottwald [États-Unis] ; Michael J. Aminoff [États-Unis] | Therapies for dopaminergic‐induced dyskinesias in parkinson disease |
| 000115 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
| 000116 (2011) |
Hana Srovnalova [République tchèque] ; Radek Marecek [République tchèque] ; Irena Rektorova [République tchèque] | The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: A pilot rTMS study |
| 000117 (2011) |
Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark] | The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists |
| 000118 (2011) |
Frédéric Moisan [France] ; Johan Spinosi [France] ; Jean-Luc Dupupet [France] ; Laurène Delabre [France] ; Jean-Louis Mazurie [France] ; Marcel Goldberg [France] ; Ellen Imbernon [France] ; Christophe Tzourio [France] ; Alexis Elbaz [France] | The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five french districts |
| 000119 (2011) |
Magdalena Eriksson Domellöf [Suède] ; Eva Elgh [Suède] ; Lars Forsgren [Suède] | The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease |
| 000120 (2011) |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The prevalence and clinical characteristics of punding in Parkinson's disease |
| 000121 (2011) |
Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Jong Doo Lee [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] | The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status |
| 000122 (2011) |
Alexandra Gaenslen [Allemagne] ; Irene Swid [Allemagne] ; Inga Liepelt-Scarfone [Allemagne] ; Jana Godau [Allemagne] ; Daniela Berg [Allemagne] | The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease |
| 000123 (2011) |
Francisco A. Ponce [États-Unis] ; Andres M. Lozano [Canada] | The most cited works in Parkinson's disease |
| 000125 (2011) |
Alison Yarnall [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] ; David J. Burn [Royaume-Uni] | The interplay of cholinergic function, attention, and falls in Parkinson's disease |
| 000126 (2011) |
Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease |
| 000127 (2011) |
Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study |
| 000128 (2011) |
M. S. Lee [Corée du Sud] ; C. H. Lyoo [Corée du Sud] ; Y. H. Ryu [Corée du Sud] ; H. S. Lim [Corée du Sud] ; C. M. Nam [Corée du Sud] ; H. S. Kim [Corée du Sud] ; J. O. Rinne [Finlande] | The effect of age on motor deficits and cerebral glucose metabolism of Parkinson’s disease |
| 000129 (2011) |
Corinna Vossius [Norvège] ; Jan P. Larsen [Norvège] ; Carmen Janvin [Norvège] ; Dag Aarsland [Norvège] | The economic impact of cognitive impairment in Parkinson's disease |
| 000130 (2011) |
Lise Hounsgaard [Danemark] ; Birthe Pedersen [Danemark] ; Lis Wagner [Danemark] | The daily living for informal caregivers with a partner with Parkinson’s disease – an interview study of women’s experiences of care decisions and self‐management |
| 000131 (2011) |
Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | The curious case of phenocopies in families with genetic Parkinson's disease |
| 000132 (2011) |
M. Andersson [Suède] ; H. Zetterberg [Suède] ; L. Minthon [Suède] ; K. Blennow [Suède] ; E. Londos [Suède] | The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia |
| 000134 (2011) |
Kai Michael Kauther [Allemagne] ; Christine Höft [Allemagne] ; Ida Rissling [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jens Carsten Möller [Allemagne, Suisse] | The PLA2G6 gene in early‐onset Parkinson's disease |
| 000135 (2011) |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
| 000136 (2011) |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
| 000137 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000138 (2011) |
Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fiévet ; Agnès Bellanger ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben Djebara [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France] | The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial |
| 000141 (2011) |
Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting dopa‐sensitive and dopa‐resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues |
| 000143 (2011) |
René Hernández- Vargas [Mexique] ; Luis Fonseca- Ornelas [Mexique] ; Ignacio L Pez- González [Mexique] ; Juan Riesgo- Escovar [Mexique] ; Mario Zurita [Mexique] ; Enrique Reynaud [Mexique] | Synphilin suppresses α‐synuclein neurotoxicity in a Parkinson's disease Drosophila model |
| 000144 (2011) |
Nick Miller [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Katherine H. O. Deane [Royaume-Uni] ; Catherine Gibb [Royaume-Uni] | Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectives |
| 000145 (2011) |
Ludy C. Shih ; Daniel Tarsy [États-Unis] | Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease |
| 000146 (2011) |
Hélène Mollion [France] ; Peter Ford Dominey [France] ; Emmanuel Broussolle [France] ; Jocelyne Ventre-Dominey [France] | Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease |
| 000147 (2011) |
Michael S. Remple [États-Unis] ; Courtney H. Bradenham [États-Unis] ; C. Chris Kao [États-Unis] ; P. David Charles [États-Unis] ; Joseph S. Neimat [États-Unis] ; Peter E. Konrad [États-Unis] | Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression |
| 000148 (2011) |
Namiko Nishida [Japon] ; Tokiko Murakami [Japon] ; Kunihiro Kadoh [Japon] ; Rie Tohge [Japon] ; Miki Yamanegi [Japon] ; Hidemoto Saiki [Japon] ; Keita Ueda [Japon] ; Sadayuki Matsumoto [Japon] ; Masatsune Ishikawa [Japon] ; Jun A. Takahashi [Japon] ; Hiroki Toda [Japon] | Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease |
| 000149 (2011) |
Brigitte Piallat [France] ; Mircea Polosan [France] ; Valérie Fraix [France] ; Laurent Goetz [France] ; Olivier David [France] ; Albert Fenoy [France] ; Napoleon Torres [France] ; Jean-Louis Quesada [France] ; Eric Seigneuret [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Thierry Bougerol [France] ; Alim-Louis Benabid [France] ; Stéphan Chabardès [France] | Subthalamic neuronal firing in obsessive‐compulsive disorder and Parkinson disease |
| 000152 (2011) |
F. Valldeoriola ; C. Coronell [Espagne] ; C. Pont ; M. T. Buongiorno ; A. Cámara ; C. Gaig ; Y. Compta | Socio‐demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON study |
